If Lgr4 loss in humans similarly induces insulin resistance, it could exacerbate the risk of developing diabetes, particularly type-2 diabetes, which is characterized by insulin resistance and impaired insulin secretion. This evidence concerns the gene INS and diabetes mellitus.